These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 14533504)

  • 41. Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy.
    Stone KB; Oddis CV; Fertig N; Katsumata Y; Lucas M; Vogt M; Domsic R; Ascherman DP
    Arthritis Rheum; 2007 Sep; 56(9):3125-31. PubMed ID: 17763431
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical significance of anti-histidyl-tRNA synthetase (Jo1) autoantibodies.
    Gomard-Mennesson E; Fabien N; Cordier JF; Ninet J; Tebib J; Rousset H
    Ann N Y Acad Sci; 2007 Aug; 1109():414-20. PubMed ID: 17785330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characteristics of antisynthetase syndrome patients with hyperferritinaemia.
    Kobayashi S; Shoda H; Seri Y; Nagafuchi Y; Sasaki O; Kubo K; Fujio K; Yamamoto K
    Scand J Rheumatol; 2017 Mar; 46(2):161-163. PubMed ID: 27308737
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies.
    Sato S; Kuwana M; Hirakata M
    Rheumatology (Oxford); 2007 May; 46(5):842-5. PubMed ID: 17255133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A 47-year-old woman with worsening dyspnea, arthritis, and muscle pain.
    Merchant M; Lewis M
    Chest; 2012 Aug; 142(2):528-531. PubMed ID: 22871765
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen.
    Hengstman GJ; Vree Egberts WT; Seelig HP; Lundberg IE; Moutsopoulos HM; Doria A; Mosca M; Vencovsky J; van Venrooij WJ; van Engelen BG
    Ann Rheum Dis; 2006 Feb; 65(2):242-5. PubMed ID: 16410528
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies.
    Mielnik P; Wiesik-Szewczyk E; Olesinska M; Chwalinska-Sadowska H; Zabek J
    Autoimmunity; 2006 May; 39(3):243-7. PubMed ID: 16769658
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical implications of autoantibody screening in patients with autoimmune myositis.
    Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
    Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Dense cytoplasmic fluorescence on Hep-2 cells: do not overlook anti-PL].
    Krebs M; Evrard B; Espinouze T; Bonnafoux C; Fabien N; Tridon A
    Pathol Biol (Paris); 2008 Feb; 56(1):15-20. PubMed ID: 18178329
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-tRNA Synthetase-specific Immunofluorescence Patterns are Easily Detected in the Suitable Substrate.
    Jearn LH; Kim TY
    J Rheumatol; 2017 Oct; 44(10):1564-1565. PubMed ID: 28966173
    [No Abstract]   [Full Text] [Related]  

  • 51. Glu-Q-tRNA(Asp) synthetase coded by the yadB gene, a new paralog of aminoacyl-tRNA synthetase that glutamylates tRNA(Asp) anticodon.
    Blaise M; Becker HD; Lapointe J; Cambillau C; Giegé R; Kern D
    Biochimie; 2005; 87(9-10):847-61. PubMed ID: 16164993
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cancer-associated myositis in the presence of anti-Jo1 autoantibodies and the antisynthetase syndrome.
    Legault D; McDermott J; Crous-Tsanaclis AM; Boire G
    J Rheumatol; 2008 Jan; 35(1):169-71. PubMed ID: 18176990
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunogenetic features in 120 Japanese patients with idiopathic inflammatory myopathy.
    Furuya T; Hakoda M; Tsuchiya N; Kotake S; Ichikawa N; Nanke Y; Nakajima A; Takeuchi M; Nishinarita M; Kondo H; Kawasaki A; Kobayashi S; Mimori T; Tokunaga K; Kamatani N
    J Rheumatol; 2004 Sep; 31(9):1768-74. PubMed ID: 15338498
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhancing the utility of unnatural amino acid synthetases by manipulating broad substrate specificity.
    Stokes AL; Miyake-Stoner SJ; Peeler JC; Nguyen DP; Hammer RP; Mehl RA
    Mol Biosyst; 2009 Sep; 5(9):1032-8. PubMed ID: 19668869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-synthetase syndrome diagnosed during pregnancy: a case report and literature review.
    Mourot A; Mahone M; Manganas H; Bourré-Tessier J; Landon-Cardinal O
    Scand J Rheumatol; 2024 May; 53(3):229-232. PubMed ID: 38346225
    [No Abstract]   [Full Text] [Related]  

  • 56. Do tissue levels of autoantigenic aminoacyl-tRNA synthetase predict clinical disease?
    Kron MA; Petridis M; Haertlein M; Libranda-Ramirez B; Scaffidi LE
    Med Hypotheses; 2005; 65(6):1124-7. PubMed ID: 16085368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amino acid sensing using aminoacyl-tRNA synthetase.
    Kugimiya A; Morii M; Ohtsuki T
    Anal Biochem; 2008 Jul; 378(1):90-2. PubMed ID: 18410738
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Myositis-specific and associated autoantibodies].
    Kuwana M
    Rinsho Shinkeigaku; 2011 Nov; 51(11):960. PubMed ID: 22277438
    [No Abstract]   [Full Text] [Related]  

  • 59. Evidence for MHC I-restricted CD8+ T-cell-mediated immunopathology in canine masticatory muscle myositis and polymyositis.
    Neumann J; Bilzer T
    Muscle Nerve; 2006 Feb; 33(2):215-24. PubMed ID: 16270307
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural characterization of a p-acetylphenylalanyl aminoacyl-tRNA synthetase.
    Turner JM; Graziano J; Spraggon G; Schultz PG
    J Am Chem Soc; 2005 Nov; 127(43):14976-7. PubMed ID: 16248607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.